Recurrent Supraventricular Tachycardia as a Complication of Nebulized Albuterol Treatment

Abstract

Get full access to this article

View all access options for this article.

References

1. Gross KM , Ponte CD . New strategies in the medical management of asthma. Am Fam Phys. 1998;58:89-100.

2. Guidelines for the diagnosis and management of asthma . National Asthma Education Program. National Heart, Lung and Blood Institute, National Institute of Health, Bethesda, Maryland. Publication #91-3042 A. June 1991.

3. Keller KA , Bhisitkul DM . Supraventricular tachycardia:a complication of nebulized albuterol. Pediatr Emerg Care. 1995;11:98-99.

4. Breeden CC , Safirstein BH . Albuterol and spacer induced atrial fibrillation. Chest. 1990;98:762-763.

5. Cook P , Scarfone RJ , Cook RT . Adenosine in the termination of albuterolinduced supraventricular tachycardia. Ann Emerg Med. 1994;24:316-319.

6. Ludomirsky A , Garson A. Supraventricular tachycardia. In: Garson A , Bricker T , Fisher D , Neish S , eds. The Science and Practice of Pediatric Cardiology, 1st ed. Baltimore:Williams & Wilkins;1990:1809-1843.

7. Till J , Shinebourne EA , Rigby ML , et al. Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children. Br HeartJ. 1989;62:204-211.

8. Rossi AF , Burton DA . Adenosine in altering short and long term treatment of supraventricular tachycardia in infants. Ann Emerg Med. 1992;21:1499-1501.

9. Hall IP , Woodhead MA , Johnston ID . Effect of high dose salbutamol on cardiac rhythm in severe chronic airflow obstruction:a controlled study. Respiration. 1994;61:214-218.

10.

10. Lin RY , Smith AJ , Hergenroeder P. High serum albuterol levels and tachycardia in adult asthmatics treated with high dose continuously aerosolized albuterol. Chest. 1993;103:221-225.